doi: 10.1016/0006-2952(89)90677-1
It is particularly well suited for patients with a BMI of 35 or greater, or significant obesity-related metabolic conditions including type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), or severe insulin resistance, who have tried semaglutide or tirzepatide without achieving adequate weight loss results, who have significant metabolic resistance meaning their physiology actively resists weight loss through compensatory hormonal mechanisms, who need the most potent available tool for weight reduction alongside lifestyle changes and medical supervision, or who are seeking to avoid bariatric surgery but need a comparable level of intervention
There is no advantage to using the light sensitive forms of cobalamin, such as methylB 12 or adenosylB 12 , instead of the stable cyano or hydroxy forms, which are readily converted in the body into the coenzyme forms, methylB 12 and adenosylB 12
Certain weight loss injections can help in reducing insulin resistance and improving overall metabolic health
The GIP receptor (tirzepatide and retatrutide activate this)